Table 5.
Human Immunodeficiency Virus (HIV) Drug Resistance in Infants at Time of Diagnosis by Antiretroviral Class and Timing of Vertical Transmission
In utero or Peripartum Vertical Transmission | Breastfeeding Vertical Transmission | |
---|---|---|
Number and Antiretroviral Drug Class With Resistance Mutations Detected | n = 41 (53.3%) | n = 36 (46.7%) |
NRTI | ||
Single | … | 3 (8.3%) |
Multiple | … | … |
NNRTI | ||
Single | 5 (12.2%) | 8 (22.2%) |
Multiple | … | 7 (19.4%) |
NRTI and NNRTI | … | 1 (2.8%) |
Total number (%; 95% CI) | 5 (12.5%; 4.1%, 26.2%) | 19 (52.8%; 35.5%, 69.6%) |
Abbreviations: CI, confidence interval; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors.